Portfolio concentration
As of June 30, 2024 · N-PORT
Holdings
266
Top-10 weight
26.78%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
77
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
332.1
Holdings
As of June 30, 2024 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | ALNYLAM PHARMACEUTICALS INC | — | 3,517 | $854.63K | 5.20% |
| 2 | MODERNA INC | — | 4,955 | $588.41K | 3.58% |
| 3 | SAREPTA THERAPEUTICS INC | — | 3,320 | $524.56K | 3.19% |
| 4 | NATERA INC | — | 4,281 | $463.59K | 2.82% |
| 5 | ILLUMINA INC | — | 3,846 | $401.45K | 2.44% |
| 6 | CATALENT INC | — | 6,413 | $360.60K | 2.19% |
| 7 | INSMED INC | — | 5,343 | $357.98K | 2.18% |
| 8 | ROIVANT SCIENCES LTD | — | 28,688 | $303.23K | 1.84% |
| 9 | VAXCYTE INC | — | 3,836 | $289.66K | 1.76% |
| 10 | EXACT SCIENCES CORP | — | 6,432 | $271.75K | 1.65% |
| 11 | CEREVEL THERAPEUTICS HOLDINGS INC | — | 6,422 | $262.60K | 1.60% |
| 12 | ELANCO ANIMAL HEALTH INC | — | 17,563 | $253.43K | 1.54% |
| 13 | IONIS PHARMACEUTICALS INC | — | 5,178 | $246.78K | 1.50% |
| 14 | BLUEPRINT MEDICINES CORP | — | 2,196 | $236.68K | 1.44% |
| 15 | INTRA-CELLULAR THERAPIES INC | — | 3,432 | $235.06K | 1.43% |
| 16 | REVOLUTION MEDICINES INC | — | 5,864 | $227.58K | 1.38% |
| 17 | GLAUKOS CORP | — | 1,766 | $209.01K | 1.27% |
| 18 | VIKING THERAPEUTICS INC | — | 3,859 | $204.57K | 1.24% |
| 19 | MADRIGAL PHARMACEUTICALS INC | — | 718 | $201.15K | 1.22% |
| 20 | SUMMIT THERAPEUTICS INC | — | 25,617 | $199.81K | 1.22% |
| 21 | CYTOKINETICS INC | — | 3,648 | $197.65K | 1.20% |
| 22 | TRANSMEDICS GROUP INC | — | 1,204 | $181.35K | 1.10% |
| 23 | BRIDGEBIO PHARMA INC | — | 6,560 | $166.16K | 1.01% |
| 24 | APELLIS PHARMACEUTICALS INC | — | 4,272 | $163.87K | 1.00% |
| 25 | NUVALENT INC-A | — | 2,103 | $159.53K | 0.97% |
| 26 | IMMUNITYBIO INC | — | 24,334 | $153.79K | 0.94% |
| 27 | INSPIRE MEDICAL SYSTEMS INC | — | 1,063 | $142.26K | 0.87% |
| 28 | AXSOME THERAPEUTICS INC | — | 1,709 | $137.57K | 0.84% |
| 29 | IMMUNOVANT INC | — | 5,208 | $137.49K | 0.84% |
| 30 | CRINETICS PHARMACEUTICALS INC | — | 2,819 | $126.26K | 0.77% |
| 31 | AVIDITY BIOSCIENCES | — | 3,004 | $122.71K | 0.75% |
| 32 | ULTRAGENYX PHARMA INC | — | 2,974 | $122.23K | 0.74% |
| 33 | IRHYTHM TECHNOLOGIES INC | — | 1,119 | $120.45K | 0.73% |
| 34 | DENALI THERAPEUTICS INC | — | 5,095 | $118.31K | 0.72% |
| 35 | ARROWHEAD PHARMACEUTICALS INC | — | 4,488 | $116.64K | 0.71% |
| 36 | PROCEPT BIOROBOTICS CORP | — | 1,878 | $114.73K | 0.70% |
| 37 | AZENTA INC | — | 2,025 | $106.56K | 0.65% |
| 38 | TWIST BIOSCIENCE CORP | — | 2,157 | $106.30K | 0.65% |
| 39 | AMICUS THERAPEUTICS INC | — | 10,711 | $106.25K | 0.65% |
| 40 | DYNE THERAPEUTICS INC | — | 3,003 | $105.98K | 0.64% |
| 41 | ICU MEDICAL INC | — | 889 | $105.57K | 0.64% |
| 42 | ARCELLX INC | — | 1,909 | $105.36K | 0.64% |
| 43 | INARI MEDICAL INC | — | 2,148 | $103.43K | 0.63% |
| 44 | BIOHAVEN LTD | — | 2,937 | $101.94K | 0.62% |
| 45 | TG THERAPEUTICS INC | — | 5,704 | $101.47K | 0.62% |
| 46 | SPRINGWORKS THERAPEUTICS INC | — | 2,667 | $100.47K | 0.61% |
| 47 | ADMA BIOLOGICS INC | — | 8,800 | $98.38K | 0.60% |
| 48 | TANDEM DIABETES CARE INC | — | 2,418 | $97.42K | 0.59% |
| 49 | IDEAYA BIOSCIENCES | — | 2,711 | $95.18K | 0.58% |
| 50 | AGIOS PHARMACEUTICALS INC | — | 2,148 | $92.62K | 0.56% |
1 / 6
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.